Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%. The other most-watched exchange-traded fund that tracks the biotech sector, the...
Tag: Nkarta
Biotech Stock Nkarta Skyrockets; How Its Natural Killer Cancer Drugs Did Their Job
Nkarta (NKTX) announced promising results from two studies in blood cancer patients on Monday, leading the tiny biotech stock to score a triple-digit gain. X The company tested its “natural kill...
Here is why Nkarta is 40% up
Nkarta Inc. (NASDAQ: NKTX) is up 40% after announcing positive preliminary Phase 1 findings from its dose-finding trials of NKX101 and NKX019 in hematological malignancies. NKX101 and NKX019 are two l...